Regeneron to defend against DOJ complaint on drug-price manipulation By Reuters
[ad_1] (Reuters) -Regeneron Pharmaceuticals said on Monday it seeks to defend against U.S. Department of Justice’s complaint that alleged the company misreported the average sales...
US Justice department files complaint against Regeneron, alleges fraudulent drug pricing By Reuters
[ad_1] (Reuters) – The U.S. Justice Department said on Wednesday it had filed a false claims act complaint against Regeneron (NASDAQ:) Pharmaceuticals, claiming the company...
Regeneron preliminary Q4 US sales of Eylea below expectations By Reuters
[ad_1] © Reuters. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, U.S....